| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |